Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 8 studies | 26% ± 11% | |
dendritic cell | 8 studies | 43% ± 14% | |
conventional dendritic cell | 6 studies | 24% ± 8% | |
monocyte | 5 studies | 29% ± 9% | |
innate lymphoid cell | 5 studies | 34% ± 13% | |
group 3 innate lymphoid cell | 5 studies | 55% ± 13% | |
myeloid cell | 4 studies | 26% ± 4% | |
monocyte-derived dendritic cell | 3 studies | 57% ± 29% |
Insufficient scRNA-seq data for expression of IL4I1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 98% | 187.21 | 565 / 578 | 82% | 21.58 | 942 / 1155 |
kidney | 99% | 302.65 | 88 / 89 | 78% | 17.86 | 706 / 901 |
uterus | 77% | 39.35 | 131 / 170 | 79% | 22.32 | 364 / 459 |
breast | 87% | 75.97 | 398 / 459 | 68% | 15.56 | 765 / 1118 |
intestine | 79% | 94.90 | 765 / 966 | 64% | 12.09 | 335 / 527 |
ovary | 45% | 18.79 | 81 / 180 | 97% | 107.08 | 415 / 430 |
bladder | 81% | 48.62 | 17 / 21 | 59% | 14.77 | 295 / 504 |
skin | 58% | 39.73 | 1055 / 1809 | 69% | 25.58 | 328 / 472 |
stomach | 54% | 32.42 | 195 / 359 | 70% | 13.57 | 200 / 286 |
pancreas | 56% | 23.58 | 184 / 328 | 65% | 11.72 | 115 / 178 |
esophagus | 50% | 28.07 | 721 / 1445 | 52% | 7.77 | 95 / 183 |
lymph node | 0% | 0 | 0 / 0 | 100% | 269.91 | 29 / 29 |
spleen | 99% | 193.56 | 239 / 241 | 0% | 0 | 0 / 0 |
prostate | 80% | 63.49 | 197 / 245 | 14% | 1.57 | 72 / 502 |
adipose | 94% | 124.31 | 1126 / 1204 | 0% | 0 | 0 / 0 |
thymus | 49% | 35.68 | 323 / 653 | 41% | 7.53 | 246 / 605 |
tonsil | 0% | 0 | 0 / 0 | 89% | 29.71 | 40 / 45 |
brain | 63% | 40.52 | 1659 / 2642 | 21% | 3.22 | 147 / 705 |
adrenal gland | 76% | 35.95 | 196 / 258 | 3% | 0.30 | 7 / 230 |
peripheral blood | 76% | 2154.67 | 704 / 929 | 0% | 0 | 0 / 0 |
liver | 47% | 22.85 | 106 / 226 | 24% | 4.64 | 97 / 406 |
blood vessel | 66% | 58.88 | 887 / 1335 | 0% | 0 | 0 / 0 |
heart | 35% | 19.90 | 305 / 861 | 0% | 0 | 0 / 0 |
muscle | 18% | 7.98 | 144 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 15% | 1.80 | 12 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045577 | Biological process | regulation of B cell differentiation |
GO_0002841 | Biological process | negative regulation of T cell mediated immune response to tumor cell |
GO_0006559 | Biological process | L-phenylalanine catabolic process |
GO_0019440 | Biological process | tryptophan catabolic process to indole-3-acetate |
GO_0009063 | Biological process | amino acid catabolic process |
GO_0050868 | Biological process | negative regulation of T cell activation |
GO_0002819 | Biological process | regulation of adaptive immune response |
GO_0006569 | Biological process | tryptophan catabolic process |
GO_0002250 | Biological process | adaptive immune response |
GO_0042130 | Biological process | negative regulation of T cell proliferation |
GO_0045591 | Biological process | positive regulation of regulatory T cell differentiation |
GO_0006572 | Biological process | tyrosine catabolic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0001772 | Cellular component | immunological synapse |
GO_0001669 | Cellular component | acrosomal vesicle |
GO_0005576 | Cellular component | extracellular region |
GO_0005764 | Cellular component | lysosome |
GO_0097225 | Cellular component | sperm midpiece |
GO_0046592 | Molecular function | polyamine oxidase activity |
GO_0001716 | Molecular function | L-amino-acid oxidase activity |
GO_0106329 | Molecular function | L-phenylalaine oxidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | IL4I1 |
Protein name | Amine oxidase (EC 1.4.3.-) Interleukin 4 induced 1 L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2) (EC 1.4.3.25) (Interleukin-4-induced protein 1) (IL4-induced protein 1) (hIL4I1) (Protein Fig-1) (hFIG1) |
Synonyms | FIG1 UNQ636/PRO1265 |
Description | FUNCTION: Secreted L-amino-acid oxidase that acts as a key immunoregulator . Has preference for L-aromatic amino acids: converts phenylalanine (Phe), tyrosine (Tyr) and tryptophan (Trp) to phenylpyruvic acid (PP), hydroxyphenylpyruvic acid (HPP), and indole-3-pyruvic acid (I3P), respectively . Also has weak L-arginine oxidase activity . Acts as a negative regulator of anti-tumor immunity by mediating Trp degradation via an indole pyruvate pathway that activates the transcription factor AHR . IL4I1-mediated Trp catabolism generates I3P, giving rise to indole metabolites (indole-3-acetic acid (IAA) and indole-3-aldehyde (I3A)) and kynurenic acid, which act as ligands for AHR, a ligand-activated transcription factor that plays important roles in immunity and cancer . AHR activation by indoles following IL4I1-mediated Trp degradation enhances tumor progression by promoting cancer cell motility and suppressing adaptive immunity . Also has an immunoregulatory function in some immune cells, probably by mediating Trp degradation and promoting downstream AHR activation: inhibits T-cell activation and proliferation, promotes the differentiation of naive CD4(+) T-cells into FOXP3(+) regulatory T-cells (Treg) and regulates the development and function of B-cells . Also regulates M2 macrophage polarization by inhibiting T-cell activation (By similarity). Also has antibacterial properties by inhibiting growth of Gram negative and Gram positive bacteria through the production of NH4(+) and H2O2 . . |
Accessions | M0QYW8 ENST00000596011.1 ENST00000341114.7 [Q96RQ9-2] ENST00000391826.7 [Q96RQ9-1] Q96RQ9 ENST00000601717.5 M0QYH9 ENST00000593956.5 ENST00000596022.5 ENST00000595948.5 [Q96RQ9-2] M0QXY7 ENST00000597295.5 M0R2S9 A2RRH1 M0R1L1 |